Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
KRAS
Biotech
Frontier CEO weathers one of his hardest fundraises to add $80M
Frontier has raised $80 million, but CEO Chris Varma, Ph.D., says corralling the capital was harder than the bleakest days of the Great Recession.
Max Bayer
Feb 22, 2024 4:01pm
Jazz jumps into KRAS G12D space via $10M upfront deal with Redx
Feb 7, 2024 8:30am
Hookipa, reeling from Roche's KRAS cull, lays off 30% of team
Jan 29, 2024 9:21am
Heart drug sheds light on potential pancreatic cancer therapy
Jan 2, 2024 6:30am
AstraZeneca pays $24M to join race for next big KRAS opportunity
Nov 27, 2023 6:15am
OrbiMed nets $4.3B across 3 funds
Oct 24, 2023 7:30am